Protein Engineering Congress EU, 12-13 November 2019, Frankfurt am Main, Germany
18 October 2019
Meet PEACCEL at Protein Engineering Congress EU.
Rudy PANDJAITAN (Chief Business Officer) will be representing PEACCEL at this event.
Enzyme Engineering XXV, 15-19 September 2019, Whistler, British Columbia, Canada
14 September 2019
Meet PEACCEL at Enzyme Engineering XXV.
Rudy PANDJAITAN (Chief Business Officer) will be representing PEACCEL at this event.
14th International Symposium on Biocatalysis and Biotransformations (BioTrans 2019), 7–11 July 2019, Groningen, The Netherlands
5 July 2019
Meet PEACCEL at the Biotrans 2019.
Rudy PANDJAITAN (Chief Business Officer) will be representing PEACCEL at this event.
PEACCEL secures new funding.
20 March 2019
PEACCEL’s "Development of polypeptides by protein design" R&D program aims to develop a virtual platform for obtaining polypeptides with superior capacities, for the pharmaceutical and chemical industries.
Results: Virtual platform, proprietary molecules, POCs, and extension of international partnerships.
Annual Conference 2019 of the Association for General and Applied Microbiology, 17–20 March 2019, Mainz, Germany
17 March 2019
Meet PEACCEL at the VAAM 2019.
Rudy PANDJAITAN (Chief Business Officer) will be representing PEACCEL at this event.
PEACCEL will give a presentation “innov’SAR: a new approach for protein engineering and screening” on March 18 between 18:00-18:30.
Publication of two articles describing PEACCELs’ proprietary innov’SAR technology and its successful application in the improvement of an industrial enzyme
23 November 2018
PEACCEL announced the publication of a two research articles describing PEACCELs’ proprietary innov’SAR technology and its application in the improvement of enzymes. The first article with the title “Application of fourier transform and proteochemometrics principles to protein engineering” was published in BMC Bioinformatics. The second article entitled “A machine learning approach for reliable prediction of amino acid interactions and its application in the directed evolution of enantioselective enzymes” was published in Scientific Reports, a Nature Publishing Group journal,
The first article describes PEACCELs’ algorithm innov’SAR and its capacity to describe and to model properties of different proteins ranging from peptides to enzymes and receptors. The second article which was done in collaboration with the research group of Manfred Reetz, one of the leading scientists in the field of enzyme evolution illustrates the successful application of innov’SAR for the accurate prediction of improved epoxide hydrolases.
“With these publications we have achieved a further key milestone in our company development as we could successfully demonstrate the power of our innov’SAR technology to predict improved protein properties and to reduce time consuming and expensive laboratory testing. As shown in the articles innov’SAR could capture additive as well as epistatic effects of mutations and therefore obtained highly accurate predictions of their combined activities. Based on the precise innov’SAR models we could predict improved variants of an enzyme of industrial interest. The testing of a very limited number of variants (<10) resulted in the identification of several mutans with improved properties. The collaboration with M. Reetz gave us the opportunity not only to have a very critical outside opinion on our technology but also to perform a proof of concept study to demonstrate that innov’SAR can also further optimize already highly improved enzymes” commented Rudy Pandjaitan head of business development.